Bethan Psaila, MA, MBBS, MRCP, PhD, FRCPath, is a Cancer Research UK Advanced Clinician Scientist at The MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK, and an Honorary Consultant in Hematology.
Dr Psaila studied medicine at Clare College, Cambridge and University College London Hospitals. Following her MRCP, she undertook a PhD in the role of megakaryocytes in cancer metastasis, as part of a collaborative project between Imperial College London, London, UK, and Weill-Cornell University Medical School, New York, NY. After this, Dr Psaila completed her specialty training in hematology at the Hammersmith Hospital, London, UK, as an NIHR Academic Clinical Lecturer at Imperial. Then, she secured a prestigious Wellcome Career Development Fellowship, which supported her postdoctoral research at the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, and then the MRC Weatherall Institute of Molecular Medicine, University of Oxford.
Speaking on the role of megakaryocytes in cancer
Dr Psaila’s research focuses on how megakaryocytes are produced from bone marrow stem cells, how they function in healthy people and how this goes wrong in myeloproliferative neoplasms. This research aims to contribute to key pathological features of the disease, including harmful scarring that destroys the bone marrow.